Ginkgo Bioworks Holdings (DNA) Other financing activities (2020 - 2024)
Ginkgo Bioworks Holdings (DNA) posted Other financing activities of -$80000.0 for Q4 2024, down 671.43% on a QoQ basis from $14000.0 in Q2 2024, and down 106.76% year-over-year from $1.2 million in Q1 2024.
Ginkgo Bioworks Holdings (DNA) Other financing activities (2020 - 2024) Analysis & Trends
Ginkgo Bioworks Holdings' Other financing activities history runs 5 years deep, the most recent figure standing at -$80000.0 for Q4 2024.
- Quarterly Other financing activities fell 106.76% year-over-year to -$80000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$80000.0 (down 106.31% YoY) and the FY2024 annual result came in at $4000.0, down 99.31% from the prior year.
- Other financing activities was -$80000.0 for Q4 2024 at Ginkgo Bioworks Holdings, down from $14000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $100.3 million in Q4 2022 and bottomed at -$980000.0 in Q2 2022.
- A 5-year average of $6.3 million and a median of $12000.0 in 2021 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 79500.0% in 2022, while the deepest fall reached 8266.67% in 2022.
- Ginkgo Bioworks Holdings' Other financing activities stood at $7000.0 in 2020, then surged by 1700.0% to $126000.0 in 2021, then surged by 79500.0% to $100.3 million in 2022, then plunged by 98.82% to $1.2 million in 2023, then tumbled by 106.76% to -$80000.0 in 2024.
- Business Quant data shows DNA's Other financing activities at -$80000.0 in Q4 2024, $14000.0 in Q2 2024, and $70000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -80,000.00 |
| Dec 31, 2024 | -80,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -615,000.00 |
| Jun 30, 2023 | -615,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 100.30 Mn |
| Dec 31, 2022 | 100.30 Mn |
| Sep 30, 2022 | -88,000.00 |
| Sep 30, 2022 | -88,000.00 |
| Jun 30, 2022 | -980,000.00 |
| Jun 30, 2022 | -980,000.00 |